Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
50
BXMX Quote, Financials, Valuation and Earnings
Last price:
$13.89
Seasonality move
:
-0.04%
Day range:
$13.82 - $13.96
52-week range:
$12.45 - $14.30
Dividend yield:
0.81%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
172.8K
Avg. volume:
198K
1-year change:
8.72%
Market cap:
--
Revenue:
$242.2M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Nuveen S&P 500 Buy-Write Income Fund has -- downside to fair value with a price target of -- per share.
BXMX vs. S&P 500
-
Over the past 5 trading days, Nuveen S&P 500 Buy-Write Income Fund has underperformed the S&P 500 by -1.68% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nuveen S&P 500 Buy-Write Income Fund does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nuveen S&P 500 Buy-Write Income Fund has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Nuveen S&P 500 Buy-Write Income Fund reported revenues of --.
Earnings Growth
-
Nuveen S&P 500 Buy-Write Income Fund has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nuveen S&P 500 Buy-Write Income Fund reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-08 | 2024-01-08 | 2024-01-08 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8M | $955.7K | $1.2M | $20.7M | $31.4M | |
| Total Assets | $1.3B | $1.6B | $1.4B | $1.5B | $1.6B | |
| Current Liabilities | $32.5M | $21.7M | $23.7M | $33.9M | $25.5M | |
| Total Liabilities | $61.9M | $52.9M | $41.9M | $76M | $56.3M | |
| Total Equity | $1.3B | $1.5B | $1.3B | $1.4B | $1.5B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-08 | 2024-01-08 | 2024-01-08 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
BXMX
Sector
Market Cap
--
--
Price % of 52-Week High
96.78%
--
Dividend Yield
0.81%
--
Shareholder Yield
--
--
1-Year Price Total Return
8.72%
--
Beta (5-Year)
0.868
--
Dividend yield:
0.81%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$13.93
200-day SMA
Buy
Level
$13.44
Bollinger Bands (100)
Buy
Level
13.47 - 13.97
Chaikin Money Flow
Buy
Level
8.6M
20-day SMA
Sell
Level
$13.94
Relative Strength Index (RSI14)
Sell
Level
46.92
ADX Line
Sell
Level
20.91
Williams %R
Neutral
Level
-39.1304
50-day SMA
Sell
Level
$13.90
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
27.8M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.
Stock Forecast FAQ
In the current month, BXMX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BXMX average analyst price target in the past 3 months is --.
-
Where Will Nuveen S&P 500 Buy-Write Income Fund Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nuveen S&P 500 Buy-Write Income Fund share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Nuveen S&P 500 Buy-Write Income Fund?
Analysts are divided on their view about Nuveen S&P 500 Buy-Write Income Fund share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nuveen S&P 500 Buy-Write Income Fund is a Sell and believe this share price will rise from its current level to --.
-
What Is Nuveen S&P 500 Buy-Write Income Fund's Price Target?
The price target for Nuveen S&P 500 Buy-Write Income Fund over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BXMX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nuveen S&P 500 Buy-Write Income Fund is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BXMX?
You can purchase shares of Nuveen S&P 500 Buy-Write Income Fund via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nuveen S&P 500 Buy-Write Income Fund shares.
-
What Is The Nuveen S&P 500 Buy-Write Income Fund Share Price Today?
Nuveen S&P 500 Buy-Write Income Fund was last trading at $13.89 per share. This represents the most recent stock quote for Nuveen S&P 500 Buy-Write Income Fund. Yesterday, Nuveen S&P 500 Buy-Write Income Fund closed at $13.84 per share.
-
How To Buy Nuveen S&P 500 Buy-Write Income Fund Stock Online?
In order to purchase Nuveen S&P 500 Buy-Write Income Fund stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is down 0.01% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is down 0.4% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 9.72% over the past day.
